Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
Members of Congress who traded ERAS
No member of Congress has reported a trade in Erasca, Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.